Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study

MLA

P.-A. Becherel, et al. “Improvement of Patient Outcomes Following Therapeutic Optimization of Chronic Urticaria: Two-Year Data from France as Part of the International Real-Life AWARE Study.” European Journal of Dermatology, vol. 31, Apr. 2021, pp. 217–24. EBSCOhost, https://doi.org/10.1684/ejd.2021.4023.

APA

P.-A. Becherel, Michèle Debons-Peyroutet, Jean-Philippe Lacour, B. Pelvet, M. Ruer-Mulard, Audrey Lamirand, Frédéric Bérard, Pauline Pralong, Matthieu Greco, Françoise Giordano-Labadie, Gérard Guillet, & Omar Outtas. (2021). Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study. European Journal of Dermatology, 31, 217–224. https://doi.org/10.1684/ejd.2021.4023

Chicago

P.-A. Becherel, Michèle Debons-Peyroutet, Jean-Philippe Lacour, B. Pelvet, M. Ruer-Mulard, Audrey Lamirand, Frédéric Bérard, et al. 2021. “Improvement of Patient Outcomes Following Therapeutic Optimization of Chronic Urticaria: Two-Year Data from France as Part of the International Real-Life AWARE Study.” European Journal of Dermatology 31 (April): 217–24. doi:10.1684/ejd.2021.4023.